STOCK TITAN

Abpro Holdings (NASDAQ: ABP) hit with Nasdaq delisting, eyes OTC Pink trading

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Abpro Holdings, Inc. reported that Nasdaq’s Hearings Panel has decided to delist its common stock and public warrants because the company did not meet the minimum equity requirement under Nasdaq Listing Rule 5550(b)(1) by February 16, 2026. Trading on Nasdaq is scheduled to be suspended at the open on February 23, 2026.

The company has 15 days from February 18, 2026 to request a review by the Nasdaq Listing and Hearing Review Council and expects to appeal. If no appeal is pursued or successful, Nasdaq is expected to file a Form 25 to delist and deregister the securities under Section 12(b).

After Nasdaq trading is suspended, Abpro expects its common stock and public warrants to be eligible for quotation on the OTC Pink Market under the symbols “ABP” and “ABPWW.” The company warns investors that OTC Pink trading may involve reduced information, lower liquidity, and greater price volatility, and it cannot assure that any broker-dealer will make a market in its securities.

Positive

  • None.

Negative

  • Nasdaq delisting and trading suspension: Abpro did not meet Nasdaq’s minimum equity standard under Rule 5550(b)(1), and its securities are scheduled for trading suspension on Nasdaq on February 23, 2026, with a potential move to the OTC Pink Market and increased volatility and liquidity risk.

Insights

Nasdaq delisting shifts Abpro to OTC Pink with higher trading risk.

The decision by the Nasdaq Hearings Panel to delist Abpro Holdings follows the company’s failure to satisfy the minimum equity requirement in Listing Rule 5550(b)(1) by February 16, 2026. Trading suspension on Nasdaq is scheduled for the open on February 23, 2026, which moves the stock off a major exchange.

Abpro plans to appeal within the 15‑day window from February 18, 2026, but the outcome is uncertain. If the decision stands, Nasdaq is expected to file a Form 25 to delist and deregister the securities under Section 12(b), formally ending Nasdaq listing status.

The company expects quotation on the OTC Pink Market under “ABP” and “ABPWW,” but explicitly notes potential limited information availability, reduced transparency and liquidity, and greater volatility. Actual trading activity will depend on whether broker‑dealers choose to make a market after the Nasdaq suspension.

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice or transferred its listing to a different exchange.
false 0001893219 0001893219 2026-02-18 2026-02-18 0001893219 ABP:SharesOfCommonStockParValue0.0001PerShareMember 2026-02-18 2026-02-18 0001893219 ABP:WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf114.90Member 2026-02-18 2026-02-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): February 18, 2026

 

Abpro Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41224   87-1013956
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

100 Summit Drive

Burlington, MA

  01803
(Address of principal executive offices)   (Zip Code)

 

1-800-396-5890

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of Each Exchange on Which Registered
Shares of Common Stock, par value $0.0001 per share   ABP   The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $114.90   ABPWW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On February 18, 2026, Abpro Holdings, Inc. (the “Company”) received written notification from the Nasdaq Hearings Panel (the “Panel”) of the Nasdaq Stock Market LLC (“Nasdaq”) stating that, due to the Company not having met the terms of the Panel’s November 10, 2025 decision that the Company demonstrate compliance with the minimum equity standard requirement under Nasdaq Listing Rule 5550(b)(1) by February 16, 2026, the Company’s securities will be delisted from Nasdaq, and trading will be suspended at the open of trading on February 23, 2026.

 

The Company has 15 days after the date it received notice of the Panel’s decision to request that the Nasdaq Listing and Hearing Review Council (the “Council”) review the decision. The Company expects to appeal the Panel’s decision. If no appeal is taken, the Company expects Nasdaq will file a Form 25 with the SEC to delist the securities from Nasdaq and deregister the securities under Section 12(b) of the Securities Exchange Act of 1934, as amended.

 

Following suspension of trading on Nasdaq, the Company expects its common stock will be eligible for quotation on the OTC Pink Market under its existing symbol, “ABP” and its public warrants under the existing symbol “ABPWW.” The Company can provide no assurances that any broker-dealer will make a market in its common stock or public warrants or that trading levels, liquidity, or quotation prices will be maintained. The Company also cautions its stockholders and public warrant holders that trading on the OTC Pink Market may be subject to limited availability of information, reduced transparency and liquidity and greater volatility.

 

Cautionary Statement Regarding Forward-Looking Statements

 

This Current Report on Form 8-K includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this Current Report on Form 8-K that do not relate to matters of historical fact should be considered forward-looking statements, including, but not limited to, statements regarding Nasdaq’s expected filing of a Form 25 with the SEC and eligibility of the Company’s common stock and public warrants for quotation on the OTC Pink Market.

 

In some cases, you can identify forward-looking statements by terminology such as “outlook,” “aim,” “anticipate,” “assume,” “believe,” “contemplate,” “continue,” “could,” “due,” “estimate,” “expect,” “goal,” “intend,” “may,” “objective,” “plan,” “predict,” “potential,” “positioned,” “seek,” “should,” “target,” “will,” “would” and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements involve known and unknown risks, uncertainties and assumptions which may cause actual results to differ materially from any results expressed or implied by any forward-looking statement, including, but not limited to, the Company’s ability to regain compliance with the Nasdaq Listing Rule and the other important factors outlined under the caption “Risk Factors” in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on April 15, 2025, as such factors may be updated from time to time in its other filings with the SEC, which are available on the SEC’s website at www.sec.gov. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it cannot guarantee future results. The Company has no obligation, and does not undertake any obligation, to update or revise any forward-looking statement made in this Current Report on Form 8-K to reflect changes since the date of this Current Report on Form 8-K, except as may be required by law.

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ABPRO HOLDINGS, INC.
     
  By: /s/ Miles Suk
  Name:  Miles Suk
  Title: Chief Executive Officer
     
Dated: February 20, 2026    

 

2

 

FAQ

What did Abpro Holdings, Inc. (ABP) announce regarding its Nasdaq listing?

Abpro disclosed that a Nasdaq Hearings Panel decided to delist its common stock and public warrants after it failed to meet the minimum equity requirement under Rule 5550(b)(1) by February 16, 2026. Nasdaq plans to suspend trading at the open on February 23, 2026.

When will Abpro Holdings (ABP) trading be suspended on Nasdaq?

Trading in Abpro’s common stock and public warrants on Nasdaq is scheduled to be suspended at the open of trading on February 23, 2026. This follows the Nasdaq Hearings Panel’s delisting decision after the company missed the February 16, 2026 minimum equity compliance deadline.

Can Abpro Holdings (ABP) appeal the Nasdaq delisting decision?

Abpro has 15 days from receiving the Panel’s decision on February 18, 2026 to request review by the Nasdaq Listing and Hearing Review Council. The company states it expects to appeal, although the filing does not indicate any outcome or likelihood of success.

Where will Abpro Holdings (ABP) trade after Nasdaq suspends its securities?

Abpro expects its common stock to be eligible for quotation on the OTC Pink Market under the symbol “ABP” and its public warrants under “ABPWW.” The company cautions investors about potentially reduced information, lower liquidity, and greater price volatility on the OTC Pink venue.

What is the significance of Nasdaq Listing Rule 5550(b)(1) for Abpro (ABP)?

Nasdaq Listing Rule 5550(b)(1) sets a minimum equity standard companies must maintain to remain listed on the Nasdaq Capital Market. Abpro did not meet this standard by February 16, 2026, which led the Nasdaq Hearings Panel to decide to delist its securities from Nasdaq.

What happens if Abpro (ABP) does not successfully appeal the Nasdaq decision?

If Abpro does not appeal, or an appeal is unsuccessful, it expects Nasdaq will file a Form 25 with the SEC. That filing would delist its securities from Nasdaq and deregister them under Section 12(b), while trading may transition to quotation on the OTC Pink Market.

Filing Exhibits & Attachments

4 documents